MMCAP International Inc. SPC Sells 1,100,000 Shares of M3-Brigade Acquisition V Corp. $MBAV

MMCAP International Inc. SPC lessened its stake in shares of M3-Brigade Acquisition V Corp. (NASDAQ:MBAV) by 73.3% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The fund owned 400,000 shares of the company’s stock after selling 1,100,000 shares during the quarter. MMCAP International Inc. SPC’s holdings in M3-Brigade Acquisition V were worth $4,252,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently modified their holdings of MBAV. Pantera Capital Partners LP bought a new stake in shares of M3-Brigade Acquisition V during the third quarter worth $15,825,000. Meteora Capital LLC grew its stake in shares of M3-Brigade Acquisition V by 133.0% during the third quarter. Meteora Capital LLC now owns 1,475,801 shares of the company’s stock worth $15,570,000 after buying an additional 842,418 shares during the last quarter. Heights Capital Management Inc. bought a new stake in shares of M3-Brigade Acquisition V in the third quarter worth $5,275,000. TENOR CAPITAL MANAGEMENT Co. L.P. grew its stake in shares of M3-Brigade Acquisition V by 200.0% in the second quarter. TENOR CAPITAL MANAGEMENT Co. L.P. now owns 750,000 shares of the company’s stock worth $8,468,000 after purchasing an additional 500,000 shares during the last quarter. Finally, Polar Asset Management Partners Inc. grew its stake in shares of M3-Brigade Acquisition V by 64.3% in the third quarter. Polar Asset Management Partners Inc. now owns 1,200,005 shares of the company’s stock worth $12,660,000 after purchasing an additional 469,678 shares during the last quarter.

Wall Street Analyst Weigh In

MBAV has been the topic of several analyst reports. Weiss Ratings reissued a “sell (d)” rating on shares of M3-Brigade Acquisition V in a research note on Friday, March 27th. Wall Street Zen raised shares of M3-Brigade Acquisition V to a “sell” rating in a research note on Saturday, March 14th. One analyst has rated the stock with a Sell rating, According to data from MarketBeat, the company has a consensus rating of “Sell”.

M3-Brigade Acquisition V Stock Performance

MBAV stock opened at $10.80 on Wednesday. M3-Brigade Acquisition V Corp. has a 12-month low of $10.48 and a 12-month high of $13.73. The company’s fifty day simple moving average is $10.80 and its 200 day simple moving average is $10.71.

M3-Brigade Acquisition V (NASDAQ:MBAV) last released its earnings results on Thursday, May 14th. The company reported $0.05 earnings per share (EPS) for the quarter.

About M3-Brigade Acquisition V

M3-Brigade Acquisition V is a special purpose acquisition company (SPAC) sponsored by M3 Inc, a global healthcare information and technology provider, and Brigade Capital Management, an investment management firm. The company is structured as a blank‐check vehicle listed on the Nasdaq Stock Market under the ticker MBAV, with the objective of identifying and completing a business combination in the healthcare, life sciences or related sectors.

The company benefits from the operational expertise of M3’s digital health platform and real‐world data capabilities, combined with Brigade’s deep experience in credit and asset management.